Advertisement

Evaluation of the analgesic properties of acepromazine maleate, oxymorphone, medetomidine and a combination of acepromazine-oxymorphone

      Abstract

      Objective

      To determine the presence and duration of analgesia after oxymorphone, acepromazine maleate, acepromazine-oxymorphone combination and medetomidine administration in dogs.

      Study design

      Blinded, controlled study.

      Animals

      Six adult beagle dogs.

      Methods

      Each dog participated in five trials receiving acepromazine maleate (0.2 mg kg−1 IM), oxymorphone (0.2 mg kg−1 IM), acepromazine-oxymorphone drug combination (0.2 mg kg−1 each IM), medetomidine (20 μg kg−1 IM) and sterile saline (control). Two specially designed instruments were used for analgesia determination: a heat device (HD) utilized a linear ramped intensity incandescent bulb and a pressure device (PD) consisted of a pneumatic cylinder that protruded a 2.5-cm bolt. The minimum pressure and heat necessary to produce an avoidance response were determined. Analgesia testing was performed prior to and at 30-minute intervals for six hours after drug administration.

      Results

      Oxymorphone, acepromazine-oxymorphone and medetomidine significantly elevated both pressure and heat response thresholds compared to controls and acepromazine. Both medetomidine and acepromazine-oxymorphone provided a significantly longer duration of analgesia than oxymorphone. No adverse effects were observed at any of the thermal or pressure application sites.

      Conclusions

      Oxymorphone, medetomidine and acepromazine-oxymorphone produced significant analgesia with medetomidine and acepromazine-oxymorphone providing the longest duration of analgesia.

      Keywords

      To read this article in full you will need to make a payment

      References

        • Barnhart MD
        • Hubbell JA
        • Muir WW
        • et al.
        The pharmacokinetics, pharmacodynamics, and analgesic effects of rectal, intramuscular, and intravenous administration of morphine in dogs.
        Am J Vet Res. 2000; 61: 24-28
        • Briggs SL
        • Sneed K
        • Sawyer DC
        Antinociceptive effects of oxymorphone-butorphanol-acepromazine combination in cats.
        Vet Surg. 1998; 27: 466-472
        • Cornick JL
        • Hartsfield SM
        Cardiopulmonary and behavioral effects of combinations of acepromazine/butorphanol and acepromazine/oxymorphone on dogs.
        J Am Vet Med Assoc. 1992; 200: 1952-1956
        • Dohoo SE
        • O'Connor MK
        • McDonell WN
        • et al.
        A clinical comparison of oxymorphone/acepromazine and fentanyl/droperidol sedation in dogs.
        J Am Anim Hosp Assoc. 1986; 22: 313-317
        • Hargreaves K
        • Dubner R
        • Brown F
        • et al.
        A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia.
        Pain. 1988; 32: 77-88
        • Moritz AR
        • Henriques FC
        The relative importance of time and surface temperature in the causation of cutaneous burns.
        Am J Path. 1947; 23: 695-720
        • Nolan A
        • Livingston A
        • Morris R
        Techniques for comparison of thermal and mechanical nociceptive stimuli in the sheep.
        J Pharmacolog Meth. 1987; 17: 39-49
        • Pert A
        Neuropharmacology of analgesics.
        Surg Pract News. 1981; 10: 10-16
        • Pibarot P
        • Dupuis J
        • Grisneaux E
        • et al.
        Comparison of ketoprofen, oxymorphone hydrochloride, and butorphanol in treatment of postoperative pain in dogs.
        J Am Vet Med Assoc. 1997; 211: 438-444
        • Plumb DC
        Veterinary Drug Handbook. Iowa State Press, Ames, IA1999
        • Raffe MR
        Animal models for the evaluation of analgesic agents.
        in: Short CE Van Poznak A Animal Pain. Churchill Livingstone, New York1992: 453-458
        • Short CE
        Neuroleptanalgesia and alpha-adrenergic receptor analgesia.
        in: Short CE Principles and Practice of Veterinary Anesthesia. Williams & Wilkins, Baltimore1987: 47-49
        • Thurmon JC
        • Tranquilli WJ
        • Benson GJ
        Veterinary Anesthesia. Williams & Wilkins, Baltimore1996: 54-189
        • Vesal N
        • Cribb PH
        • Frketic M
        Postoperative analgesic and cardiopulmonary effects in dogs of oxymorphone administered epidurally and intramuscularly, and medetomidine administered epidurally: a comparative clinical study.
        Vet Surg. 1996; 25: 361-369
        • Virtanen R
        Pharmacological profiles of medetomidine and its antagonist antipamezole.
        Acta Vet Scand. 1989; 85: 29-37